New Zealand's TruScreen Group hits two-year high on MoU with China-based co
** Shares of TruScreen Group TRU.NZ rise 6.5% to NZ$0.0330, their highest level since May 9, 2023 ** Medical device co signs a MoU with Hangzhou Dalton Bioscience to expand its HPV-related product portfolio ** 304,990 shares change hands, 1.5 times the 30-day average of 210,177 ** Stock up 37.5% YTD, including current session's move (Reporting by Manasi Dasa in Bengaluru) ((Manasi.DasaSundeep@thomsonreuters.com;))
Recent news on Truscreen
See all newsBrief: Truscreen Group Says Tony Ho To Resume Role As Independent Non-Executive Chairman
New Zealand's TruScreen tumbles on discounted placement
Brief: Truscreen Group Says NZ Regco Has Approved A Trading Halt
Brief: Truscreen Announces Opening Of NZ$2.9 Million Capital Raise
Brief: Truscreen Group Sees FY26 Unaudited Loss